No Data
No Data
IO Biotech's Co-Founder Mads Hald Andersen Highlights Advances in Cancer Vaccine Research at 2025 AACR Annual Meeting
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
We're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Rate
Piper Sandler Sticks to Their Buy Rating for IO Biotech (IOBT)
IO Biotech | 10-K: FY2024 Annual Report
IO Biotech Announces Acceptance Of Abstracts To Be Presented At 2025 American Association for Cancer Research Annual Meeting